Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,187	1,785	2,963	1,354	1,114	955
Market Cap Growth	-34.59%	-39.75%	118.80%	21.52%	16.65%	5.51%
Enterprise Value	1,598	2,165	3,336	1,273	1,106	968
Last Close Price	24.79	37.13	61.85	28.02	23.29	20.11
PE Ratio	8.96	11.19	21.54	14.82	17.94	680.90
Forward PE	7.85	9.42	20.77	16.29	16.96	23.74
PS Ratio	1.64	2.44	4.60	2.71	2.55	2.73
PB Ratio	1.57	2.44	4.63	2.56	2.50	2.13
P/TBV Ratio	7.09	12.60	113.42	2.76	2.74	2.64
P/FCF Ratio	7.87	10.36	20.39	20.79	15.80	40.81
P/OCF Ratio	6.12	8.37	16.15	15.19	11.37	16.68
PEG Ratio	5.76	0.99	1.07	0.86	0.89	0.95
EV/Sales Ratio	2.19	2.96	5.18	2.55	2.53	2.77
EV/EBITDA Ratio	6.44	8.38	14.03	9.63	11.65	27.85
EV/EBIT Ratio	8.21	10.54	16.70	11.85	15.43	73.07
EV/FCF Ratio	10.64	12.56	22.95	19.55	15.68	41.37
Debt / Equity Ratio	0.87	0.89	0.98	0.19	0.24	0.15
Debt / EBITDA Ratio	2.56	2.46	2.56	0.75	1.05	1.69
Debt / FCF Ratio	4.34	3.78	4.29	1.58	1.48	2.87
Asset Turnover	0.46	0.47	0.57	0.71	0.67	0.57
Inventory Turnover	2.40	2.76	2.78	2.55	2.51	1.99
Quick Ratio	1.92	2.11	1.65	2.79	2.08	1.53
Current Ratio	2.95	3.07	2.17	3.99	3.06	2.49
Return on Equity (ROE)	19.90%	23.26%	23.55%	18.76%	14.16%	0.25%
Return on Assets (ROA)	7.60%	8.31%	11.07%	9.51%	6.88%	1.36%
Return on Capital (ROIC)	9.00%	9.71%	13.18%	11.37%	8.40%	1.64%
Return on Capital Employed (ROCE)	13.60%	14.60%	15.50%	16.60%	12.60%	2.60%
Earnings Yield	11.97%	8.94%	4.64%	6.75%	5.57%	0.15%
FCF Yield	12.70%	9.65%	4.91%	4.81%	6.33%	2.45%
Buyback Yield / Dilution	3.73%	1.78%	-1.09%	-5.31%	-1.34%	1.57%

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q